Top Page
Anaergia
(TSX:ANRG)
Anaergia (ANRG) vs. iShares MSCI Canada ETF (EWC)
Anaergia Business Overview & Revenue Model
Anaergia Earnings Call Summary
Anaergia Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 111.65M | 147.22M | 162.85M | 153.58M | 128.04M |
| Gross Profit | 25.63M | 14.60M | 28.60M | 31.63M | 28.55M |
| EBITDA | -38.37M | -185.49M | -53.59M | -11.38M | -4.53M |
| Net Income | -42.89M | -182.60M | -74.71M | -9.38M | -16.82M |
Balance Sheet | |||||
| Total Assets | 233.33M | 278.67M | 935.11M | 703.91M | 452.23M |
| Cash, Cash Equivalents and Short-Term Investments | 30.22M | 22.11M | 55.38M | 79.32M | 41.16M |
| Total Debt | 71.71M | 70.89M | 377.65M | 221.50M | 168.63M |
| Total Liabilities | 180.12M | 205.08M | 592.97M | 367.30M | 326.46M |
| Stockholders Equity | -57.65M | -55.38M | 208.84M | 218.02M | 43.27M |
Cash Flow | |||||
| Free Cash Flow | -41.01M | -130.87M | -152.97M | -127.54M | -100.57M |
| Operating Cash Flow | -30.23M | -66.76M | -30.56M | -38.95M | 26.63M |
| Investing Cash Flow | 10.90M | -27.80M | -192.50M | -149.62M | -154.48M |
| Financing Cash Flow | 32.52M | 64.76M | 198.13M | 229.91M | 153.87M |
Anaergia Technical Analysis
Anaergia Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
58 Neutral | HK$13.15B | 4.79 | -3.05% | 5.94% | 3.60% | -58.57% | |
50 Neutral | C$50.18M | 1,928.57 | 0.16% | ― | 49.38% | -93.75% | |
49 Neutral | C$229.46M | ― | 105.95% | ― | -17.26% | 91.10% | |
| ― | $48.11B | 75.09 | 7.88% | 0.66% | ― | ― | |
| ― | C$71.27M | 10.04 | 38.06% | ― | ― | ― | |
| ― | $18.26B | 10.03 | -0.03% | 0.12% | ― | ― | |
| ― | C$28.01M | ― | -11.65% | ― | ― | ― |
Anaergia Corporate Events
Anaergia Inc., through its subsidiary Anaergia S.r.l., has signed an agreement to expand and upgrade the Moglia anaerobic digestion facility in northern Italy, operated by Bioenerys. This project will more than double the facility’s biomethane production, enhancing Bioenerys’ role as a solutions provider for agricultural residues and a renewable energy generator. Anaergia expects to complete the project by the end of 2026 and recognize revenues of C$11 million, further solidifying its position in the renewable natural gas industry.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc., through its subsidiary Anaergia S.r.l., has signed a contract with PreZero International to supply equipment for upgrading an anaerobic digestion facility in Bizkaia, Spain. The facility will process up to 50,000 tons of source-separated organics annually, converting them into biomethane using Anaergia’s proprietary technologies. This project marks Anaergia’s first plant in Spain and is expected to generate C$7.6 million in revenue. The upgrade will enhance the facility’s efficiency and sustainability, reinforcing Anaergia’s position as a leader in the RNG industry and contributing to environmental protection and sustainable value creation.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc., through its subsidiary Anaergia S.r.l., has entered into a binding agreement with RDR S.p.A. to supply capital equipment for a co-digestion system at the ASA Livorno wastewater treatment plant in Livorno, Italy. This project, which is the first of its kind in Italy, will combine source-separated organics and wastewater sludge to produce renewable biomethane, with construction expected to be completed by December 2026. The initiative represents a significant step for Anaergia in leveraging its global expertise to turn waste streams into valuable energy resources, thereby advancing sustainable energy solutions.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc. announced the results of its annual general meeting of shareholders, where all nominated directors were elected and Deloitte LLP was appointed as the auditor. The meeting saw participation from shareholders holding 76.73% of the company’s common shares, reinforcing Anaergia’s stable governance and commitment to its strategic goals in the renewable energy sector.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc., through its subsidiary Anaergia S.r.l., has expanded its collaboration with Techbau S.p.A. to build two additional biomethane production plants in Italy, increasing the total to seven facilities. This expansion supports Italy’s sustainable energy goals and is expected to generate over C$36 million in revenue for Anaergia, highlighting the strong partnership and trust between the two companies.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Singapore Pte. Ltd., a subsidiary of Anaergia Inc., has signed a conditional contract with New Jeju Bio Co. Ltd. to design and build a biogas facility on Jeju Island, South Korea. This project, valued at approximately C$40 million, marks Anaergia’s first venture in South Korea and is expected to be completed by mid- to late-2027. The facility will convert organic waste into renewable energy, significantly reducing greenhouse gas emissions and promoting waste recycling on Jeju Island. This development enhances Anaergia’s market presence in South Korea and demonstrates its capability to deliver integrated waste-to-energy solutions.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc., through its subsidiary Anaergia S.r.l., has signed a C$7.3 million contract with Capwatt Biomethane Unipessoal, Lda to design and construct the Metanext anaerobic digestion facility in Italy. This project is the first of nine planned facilities aimed at enhancing Europe’s green energy infrastructure and accelerating biomethane production, with a total expected revenue of over C$60 million. The Metanext facility will produce 7.6 million cubic meters of biomethane annually, marking a significant step in sustainable energy production and the energy transition in Europe.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.
Anaergia Inc. reported a record revenue backlog of $200 million for the first quarter of 2025, marking a 94.1% increase from the previous quarter, driven by capital sales in Italy and North America. Despite a slight decrease in revenue and gross profit, the company improved its adjusted EBITDA loss by 34.5% compared to the previous year, reflecting strategic actions to strengthen its financial foundation and investor confidence.
The most recent analyst rating on (TSE:ANRG) stock is a Hold with a C$1.30 price target. To see the full list of analyst forecasts on Anaergia stock, see the TSE:ANRG Stock Forecast page.